Salisbury, United Kingdom

Christopher John Davis

USPTO Granted Patents = 17 


 

Average Co-Inventor Count = 8.5

ph-index = 7

Forward Citations = 149(Granted Patents)


Location History:

  • Abingdon, GB (2013 - 2015)
  • Salisbury, GB (2012 - 2022)

Company Filing History:


Years Active: 2012-2022

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovative Mind of Christopher John Davis

Introduction

Christopher John Davis, hailing from Salisbury, GB, is a notable inventor with a remarkable portfolio comprising 17 patents. His work focuses on the development of innovative compounds aimed at medical advancements, particularly in the field of cancer treatment.

Latest Patents

Davis’s latest contributions to the field include novel compounds that serve as inhibitors of ATR protein kinase. These inventions encompass pharmaceutically acceptable compositions, methods for treating various diseases, and thorough processes for preparing these compounds. The latest patents also detail intermediates for the preparation and solid forms of these innovative compounds, identified by formulas I-A and I-B, wherein various parameters are explicitly defined.

Career Highlights

Throughout his career, Christopher has made significant strides in the pharmaceutical industry, particularly during his tenure at Vertex Pharmaceuticals, Inc. His groundbreaking research and innovative solutions have not only expanded the scientific community's understanding of ATR pathways but have also paved the way for new treatment modalities.

Collaborations

Davis has collaborated with several esteemed colleagues, including Damien Fraysse and John R Studley, showcasing his ability to work within diverse teams and contribute to collective innovation. These partnerships highlight the collaborative spirit that drives research and the importance of sharing knowledge and expertise in advancing medical science.

Conclusion

In conclusion, Christopher John Davis stands out as a pivotal figure in the realm of innovation with a focus on cancer treatment advancements. His extensive portfolio of patents and collaborative efforts with notable peers mark him as an influential inventor whose contributions continue to make a significant impact in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…